![](https://d3ilqtpdwi981i.cloudfront.net/NeLXV7sCLqG2gf04971JhMHyrH0=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/33/bd/cb/33bdcb28-0e8e-488b-9907-cf6b8ed04afa/file.jpg)
Article
DNA methylation episignatures are sensitive and specific biomarkers for detection of patients with KAT6A/KAT6B variants
Future Medicine
(2023)
Disciplines
Publication Date
2023
Citation Information
Jack Reilly. "DNA methylation episignatures are sensitive and specific biomarkers for detection of patients with KAT6A/KAT6B variants" Future Medicine (2023) Available at: http://works.bepress.com/jack-reilly/11/